NCT06809179: A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder
- State
- Completed
- Phase
- Phase 2
- People
- 61 taking part
- Started
- 9 Jan 2025
- Primary completion
- 12 Jun 2026
- Arms
- Placebo Nasal Spray
- Results
- None posted
- 9 Jan 2025: Trial started
- 5 Feb 2025: Trial registered
- 26 Aug 2026: Trial completed